BIGG

Resultados: 5

Australian guidelines for the clinical care of people with COVID-19 - Australian National COVID-19 Clinical Evidence Taskforce

This guideline aims to provide specific, patient-focused recommendations on management and care of people with suspected or confirmed COVID-19. With the exception of chemoprophylaxis for the prevention of infection in people exposed to COVID-19, the guideline does not include other interventions used in ...

Myeloma: diagnosis and management

This guideline covers the diagnosing and managing of myeloma (including smouldering myeloma and primary plasma cell leukaemia) in people aged 16 and over. It aims to improve care for people with myeloma by promoting the most effective tests and treatments for myeloma and its complications....

Guía de práctica clínica para el manejo de trombocitopenia inmune primaria aguda en población pediátrica
Clinical practice guide for the management of acute primary immune thrombocytopenia in pediatric population

Definir los criterios de diagnóstico de la enfermedad y las pruebas que se deben realizar al paciente para su evaluación. Brindar indicaciones de manejo de PTI aguda, crónica y persistente. Proponer opciones de tratamiento de acuerdo a la evidencia disponible. Dar indicación de manejo en PTI con r...

Guía de práctica clínica para la detección, tratamiento y seguimiento de Leucemias Linfoide y mieloide en población mayor de 18 años
Clinical practice guide for the detection, treatment and follow-up of lymphoid and myeloid leukemias in a population over 18 years of age

Ofrecer recomendaciones basadas en la evidencia para la prevención, detección, tratamiento y seguimiento de las queratosis actínicas, con el fin de apoyar al personal de salud en los diferentes niveles de atención, buscando garantizar una atención integral, homogénea, con calidad, equidad y eficien...

Myeloma: diagnosis and management

This guideline covers the diagnosing and managing of myeloma (including smouldering myeloma and primary plasma cell leukaemia) in people aged 16 and over. It aims to improve care for people with myeloma by promoting the most effective tests and treatments for myeloma and its complications....